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Large-scale multi-centre randomized controlled trials (RCTs)
are regarded as the gold standard in rigorous, robust clinical
research. Rates of participant recruitment, however, are often
challenging and can have major impact on the planning, exe-
cution and funding of trials. Failure to recruit sufficient num-
bers of participants, or extended delays in recruitment, can
threaten the trial’s success and resources, in terms of both time
and money. Trials frequently fail to recruit to target. In 2007,
Campbell and colleagues reported that more than 80% of all
trials fall short of their accrual goals, potentially seriously
compromising the validity of the findings [1]. UK publicly
funded (Medical Research Council and Health Technology
Assessment) trials are no more successful. Between 1 January
1994 and 31 December 2002, only 35 ⁄114 (31%) of trials
recruited successfully (i.e. equal to or above original recruit-
ment target).
Several common factors contribute to poor recruitment,
including overestimation of the pool of available and suitable
participants, underestimation of the time required to recruit
participants across multiple centres, willingness of both patients
and clinicians to participate, and lack of contingency plans
when recruiting fails [2]. We conducted a survey of people who
declined to take part in the pilot study to inform development
of the Relative Effectiveness of Pumps Over Structured Edu-
cation trial (REPOSE) trial. The aims were to explore the
reasons for non-participation in the pump pilot study, under-
standing of insulin pump therapy and to use this information to
inform recruitment processes in the multi-centre REPOSE
randomized controlled trial.
Ethics approval was received from the National Health
Service (NHS) Central Office for Research Ethics Committees.
Participants were selected from those who had completed a
screening questionnaire asking them about their reasons for not
wishing to participate in the pump pilot and who had expressed
a willingness to be interviewed to discuss their non-partici-
pation to the trial. Eight participants were selected covering a
representative cross section of reasons for non-participation.
Interviews ranged from 14 to 34 min (median 24.5 min). The
age range of participants was 22–59 years (median 40 years).
Duration of diabetes was 10–33 years (mean 18.8 years). All
participants were using multiple daily injection (MDI) insulin
regimens, and five had attended a Dose Adjustment for Normal
Eating (DAFNE) structured education course within the
previous 12 months. Reasons for non-participation included
lack of time, inconvenience, lack of interest in insulin pump and
satisfaction with current treatment.
Overall there was poor understanding of insulin pump
therapy, with three quarters of participants reporting very little
knowledge of either how the pump works or what it looks like.
Mixed and sometimes contradictory suggestions were proposed
for how the research team could make it easier to participate. A
desire for as much information as possible was countered with
a preference for less detail, preferring something ‘short and
succinct’. Availability face-to-face vs. availability via phone ⁄
email of healthcare professionals to discuss the research project
in more detail highlight the need for as broad a range as pos-
sible for patient contact, as well as provision of evening
appointments around work prior to having to sign up. This
personal contact preference is consistent with previous litera-
ture [3]. Perhaps the most effective approach, offering practi-
cality and personal contact would be the use of recruitment
meetings [4]. Having an insulin pump available in clinic for
potential participants to see could improve understanding and
remove some potential anxieties about constant attachment
and cannula insertion. Myths and misinformation about insulin
pumps continue to exist, and lack of knowledge about the
appearance or functions of insulin pump therapy also deter
some people.
The potential to offer participants incentives, such as shop
vouchers, to respond to questionnaires (baseline and follow-
up) was not raised in this brief study, but they may be useful
when considering how to maximize recruitment. A recent
Cochrane review reported that ‘researchers may be able to
double the odds of response by offering participants payment
for completion of questionnaires’ [3]. This could be explored
in greater detail as an extension to existing research prece-
dents; for example, cash incentives to promote smoking
cessation. Maintaining participation throughout the REPOSE
trial and 2-year follow-up is important, as the power of the
study is dependent on at least 80% of participants being
retained. A more detailed explanation of pumps and their
potential advantages and disadvantages is required prior to
inviting people to participate in large multi-centre clinical
trials.
In conclusion, the commonest reasons for non-participation
were a lack of understanding and knowledge of pump therapy
and satisfaction with current treatment. Targeted education in
providing clear explanations of the technology being evaluated,
together with its potential advantages and disadvantages, is an
important part of recruitment in large trials, and potential
recruits should be offered clear information in a way that suits
their needs.
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